Clinical Trials Directory

Trials / Completed

CompletedNCT01553734

Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?

Status
Completed
Phase
Study type
Observational
Enrollment
148 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The macrolide group of antibiotics can cause QT prolongation, and endanger the patient with life threatening arrythmias. QT prolongation caused by Azythromycin, a relatively new macrolide, is extremely rare, and was not reported in clinical trials. Our hypothesis is that patients hospitalized with severe community acquired pneumonia, usually with multiple comorbid conditions will have a higher rate of QT prolongation, compared to the clinical trials published

Detailed description

Patients hospitalized with community aquired pneumonia will have their corrected QT measured daily during antibiotic therapy. Concomittant medications and electrolyte abnormalities that cause prolonged QT will be recorded

Conditions

Timeline

Start date
2012-03-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2012-03-14
Last updated
2016-08-31

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01553734. Inclusion in this directory is not an endorsement.